Skip to main content

Table 1 Clinical features of study participants

From: Urate crystal deposition and bone erosion in gout: ‘inside-out’ or ‘outside-in’? A dual-energy computed tomography study

Male sex, n (%) 134 (93.1 %)
Age, mean (SD) 59 (12) years
Ethnicity, n (%)
 Māori
 Pacific
 Non-Māori, non-Pacific
16 (11.0 %)
63 (43.8 %)
65 (45.1 %)
Disease duration, mean (SD) 22 (12) years
Number of tophi, median (range) 4.5 (1–41)
Urate-lowering therapy use, n (%)
 None
 Allopurinol
 Probenecid
 Benzbromarone
 Combination of allopurinol plus uricosuric
4 (2.7 %)
126 (87.5 %)
4 (2.7 %)
3 (2.1 %)
7 (4.9 %)
Serum urate, mean (SD) 0.40 (0.12) mmol/L